Intuitive’s ultimate goal with Ion is to help pulmonary care teams reach answers for patients by achieving high1 diagnostic yields through a minimally invasive approach. Early research suggests Ion is meeting this goal. A newly presented preliminary abstract from a multi-center study demonstrates a diagnostic yield of 83%, a mean lesion size of 17mm, a sensitivity for cancer between 84% and 88%, and a 0% pneumothorax rate requiring a chest tube.2 A meaningful step forward in supporting lung cancer detection.
See the study abstract in the CHEST Journal.Watch the video below to hear directly from the PRECIsE study investigators.
Health Economics Outcomes Research (HEOR) is an integral part of Intuitive’s research support. Examining outcomes data helps generate evidence showing the potential role of Ion endoluminal systems in the patient journey for lung nodule biopsy.
Several recently published papers describe the current landscape of lung nodule biopsies and diagnosis. Examine the data in our publication summaries and access the full studies.
We conduct clinical studies, outcomes research, and we utilize real-world evidence (RWE) databases. Explore recent evidence.
Learn about the initial results from a single center using Ion and CBCT. The data includes preliminary evaluation of quantifying CT-to-body divergence using the combination of both technologies.
Explore a study that demonstrates real world evidence from the largest cohort of patients to date using any robotic-assisted bronchoscopic technology. The cohort includes 192 patients and 230 nodules, averaging 15mm in size. Learn about the diagnostic outcomes and safety from this single center using Ion in combination with CBCT and rEBUS.
Learn from early physician experience on using the Ion robotic-assisted bronchoscopy system in combination with 3D fluoroscopy.
Explore a recent study describing a center's initial experience with the Ion endoluminal system and cone beam CT in lung nodules—the first independent publication capturing real-world data from procedures using Ion.
Read Memorial Sloan Kettering Cancer Center’s publication on the feasibility, diagnostic yield, determinants of diagnostic sampling, and safety of ssRAB in their practice for biopsy of small peripheral nodules with median size of 1.8cm.
Learn from early physician experience in an article describing the Ion endoluminal system and practices for safe and effective use in patients with small peripheral pulmonary nodules.
View Dr. Abubakr Bajwa's recent poster presented at ATS 2021 on 76 consecutive cases of robotic-assisted navigational bronchoscopy at a single center using the Ion endoluminal system.
Find out how Ion compared with two other guided bronchoscopic approaches for investigating peripheral pulmonary nodules in a cadaver-based study.
View a comparision study of three software platforms that generate virtual airway maps and pathways to a target lesion. See segmentation capability differences between planning software for electromagnetic navigation platforms and with Ion PlanPoint.
Discover how robotic-assisted broncoscopy compared to electromagnetic navigational bronchoscopy in this cadaver-based usability study.
By submitting my information, I am agreeing to receive information regarding Intuitive products and services and related topics. More information may be found in our privacy policy.
Thank you for your information. An Intuitive representative will be in touch.
Important safety information
Risks associated with bronchoscopy through an endotracheal tube and under general anesthesia are infrequent and typically minor, and may include but are not limited to: sore throat, hoarseness, respiratory complications including dyspnea or hypoxemia, airway injury, bronchospasm, laryngospasm, fever, hemoptysis, chest or lung infection including pneumonia, lung abscess or an adverse reaction to anesthesia. Although rare, the following complications may also occur: bleeding, pneumothorax (collapsed lung), cardiac related complications, respiratory failure, air embolism, or death. As with other medical procedures, there may be additional risks associated with the use of general anesthesia and/or endotracheal intubation which are not listed above; you should consult a health care professional regarding these and other potential risks.
Procedures using the Ion Endoluminal System may be associated with longer procedure and/or longer anesthesia time.
Individuals’ outcomes may depend on a number of factors—including but not limited to—patient characteristics, disease characteristics, and/or physician experience.
Ion endoluminal system
The Ion endoluminal system (Model IF1000) assists the user in navigating a catheter and endoscopic tools in the pulmonary tract using endoscopic visualization of the tracheobronchial tree for diagnostic and therapeutic procedures. The Ion endoluminal system enables fiducial marker placement. It does not make a diagnosis and is not for pediatric use.
Information provided by the Ion endoluminal system or its components should be considered guidance only and not replace clinical decisions made by a trained physician.
The Flexision Biopsy Needle is used with the Ion Endoluminal System to biopsy tissue from a target area in the lung.
The PlanPoint Software uses patient CT scans to create a 3D plan of the lung and navigation pathways for use with the Ion Endoluminal System.